Psychiatry and Neurology, Neurology · Topeka, KS
NPI
1518962851
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
631 SW Horne St, Ste 420
Topeka, KS, 66606
Phone (785) 295-7878
Groups this clinician bills Medicare through
Medicare paid, 2024
$227K
16,557 services
Medicare patients, 2024
964
Average age 73
Drug cost, 2024
$1.2M
9,388 prescriptions
Company payments, 2025
$35.45
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wade B Welch was code J0585 (injection, onabotulinumtoxina, 1 unit), 14,602 times for 24 patients. In total Wade B Welch billed 16,557 services in 38 codes, and Medicare paid $227K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 14,602 | 24 | $4.91 | $72K |
| 99214 Office E&M - Established | Office | 707 | 607 | $76.39 | $54K |
| 95886 Electrical Nerve Conductivity | Office | 428 | 225 | $68.16 | $29K |
| 99204 Office E&M - New | Office | 187 | 187 | $111.00 | $21K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 87 | 17 | $44.76 | $3,894 |
| 95910 Electrical Nerve Conductivity | Office | 78 | 78 | $118.70 | $9,258 |
| 95911 Electrical Nerve Conductivity | Office | 74 | 74 | $134.73 | $9,970 |
| 36415 Venipuncture Blood Collection | Office | 65 | 52 | $8.65 | $562 |
| 95912 Electrical Nerve Conductivity | Office | 52 | 52 | $169.91 | $8,836 |
| 64615 Musculoskeletal | Office | 42 | 12 | $93.90 | $3,944 |
| 95819 Neurologic | Facility | 38 | 38 | $38.58 | $1,466 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 31 | 13 | $34.04 | $1,055 |
| 95816 Neurologic | Facility | 21 | 21 | $41.44 | $870 |
| 95955 Neurologic | Facility | 18 | 18 | $36.71 | $661 |
| 99213 Office E&M - Established | Office | 17 | 17 | $43.16 | $734 |
By year: 2022 $273K for 17,239 services; 2023 $246K for 17,613 services; 2024 $227K for 16,557 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 65 | 52 | $8.65 | $562 |
Medicare prescription drug claims, 2024
In 2024, the drug Wade B Welch prescribed most often to Medicare patients was Gabapentin, with 963 prescriptions and refills. In total Wade B Welch wrote 9,388 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 963 | 1,600 | 198 | $13K |
| Duloxetine Hcl Generic | 886 | 1,533 | 173 | $21K |
| Pregabalin Generic | 720 | 892 | 115 | $21K |
| Topiramate Generic | 613 | 1,018 | 111 | $7,330 |
| Memantine Hcl Generic | 599 | 898 | 112 | $15K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 569 | 963 | 106 | $14K |
| Levetiracetam Generic | 492 | 795 | 84 | $14K |
| Donepezil Hcl Generic | 411 | 730 | 95 | $4,178 |
| Tizanidine Hcl Generic | 333 | 476 | 75 | $4,858 |
| Ropinirole Hcl Generic | 201 | 366 | 40 | $4,991 |
| Nortriptyline Hcl Generic | 193 | 313 | 37 | $2,309 |
| Aimovig Autoinjector Erenumab-Aooe | 176 | 189 | 29 | $139K |
| Baclofen Generic | 172 | 227 | 27 | $3,094 |
| Trazodone Hcl Generic | 166 | 249 | 34 | $719 |
| Zonisamide Generic | 163 | 288 | 30 | $4,671 |
Brand drugs: 551 claims; generic drugs: 8,819 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wade B Welch $35.45 ($35.45 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genentech USA, Inc. with $21.66.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.